Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


DSM Venturing invests in funds targeting life sciences and performance materials

Heerlen (NL), July 18, 2005 – DSM Venturing, the corporate venturing unit of Dutch specialty maker DSM, today announced its participation in two venture capital funds. Investments in NGEN II and Life Sciences Partners III will extend the company’s window on innovation in industries of strategic importance to DSM, namely life science products and performance materials.

The NGEN II fund focuses on mid to later-stage venture investments in mainly US companies strong in materials science and active in the areas of clean and sustainable technology, advanced materials and coatings, biomaterials and electronic materials, which are all areas of interest to DSM’s activities in Performance Materials. DSM Venturing decided to participate in NGEN’s second fund to maintain the window on materials science related innovations as created by its earlier investment in NGEN’s first fund. Moreover, DSM expects to accelerate its own innovations in the performance materials area, by co-operating with small innovative companies, both directly and indirectly, via NGEN.

To specifically strengthen its innovation in the life sciences field, DSM Venturing has also invested in Life Sciences Partners III, a venture capital fund dedicated to life science investments in Europe with a Benelux and German focus. This fund was set up by LSP, a leading European venture capital firm with which DSM Venturing has previously co-operated. LSP will use the new fund to invest in 15 to 20 startup companies.

Marc Schueler, general manager DSM Venturing, comments: “Fund investments are an effective way to create dealflow in aid of our investment process in promising startup companies. With our investments in NGEN and LSP, we are reconfirming our partnership with two of the world’s leading VC companies in our key investment areas.”

About NGEN Partners
NGEN is a venture capital firm dedicated to identifying and nurturing emerging companies that address large market opportunities in the materials fields. Based in Santa Barbara, CA, the fund is engineered so as to support portfolio companies in accelerating product development progress. For more information visit

About Life Sciences Partners
Life Sciences Partners (“LSP”) is a leading European venture capital fund, providing private equity capital to early-stage life sciences companies. Based in Amsterdam and Munich, LSP’s management has focused for over a decade on investing in human life sciences. Fore more information visit

About DSM Venturing
DSM Venturing, part of the DSM Venturing & Business Development business group, is an active investor in several Venture Capital Funds and startup companies in DSM’s strategic growth fields: food ingredients, pharmaceutical intermediates and performance materials. DSM Venturing’s mission is to explore emerging markets and technologies in order to enhance DSM’s product portfolio and create value. For more information about DSM Venturing see

Publisher Contact Information:

DSM Venturing
+31 (0)45 578 3119

Company profile of DSM Venturing
Past press releases of DSM Venturing.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
May 30€15.0MBiopharmaceuticals
May 28€15.0MDiagnostics
May 28€1.3MInternet services
May 25€1.0MOther Software
May 22N/AInternet services
May 20€4.3MArtificial Intelligence

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Mar 31
the fit allocates chf 100'000 to comppair technologies

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.